Annual Meeting

Control our thoughts and better science will follow

A Discover BMB symposium: Bias In, Bias Out in Data Science
Allison C. Augustus–Wallace
By Allison C. Augustus–Wallace
Sept. 22, 2022

The COVID-19 pandemic has shined a light on the disproportionate burden that certain diseases and conditions — such as diabetes, metabolic syndrome and mental health disorders — have on historically excluded, marginalized communities. It also has drawn attention to the negative impacts of implicit biases and the social construct of race.

The American Society for Biochemistry and Molecular Biology Maximizing Access Committee’s symposia at Discover BMB in Seattle in March will examine the effects of implicit biases on science at the genomic level, including experimental design and data interpretations, and how they contribute to health disparities. This topic is of particular importance with the emerging use of genetics in the development of artificial intelligence mechanisms.

We must seek remedies and mitigate health disparities. This means asking tough questions, even of ourselves as scientists. We must examine how our implicit biases warp our lens as biomedical researchers. We must revisit our scientific past to understand better our present and, thus, prepare for our future.

Keywords: Genetics, race, implicit bias, data interpretation, health disparities, artificial intelligence.

Theme song: “Free your Mind” by En Vogue is a song that speaks to daily stereotypes, implicit biases and microaggressions that historically excluded, marginalized people face. If only those who make such judgments would free their minds, peace for all of us would follow.

This session is powered by our need, as scientists, to be mindful of our implicit biases — and the potential roles they play in our research questions, experimental designs and data analyses — so that we can mitigate them and thereby health disparities.

Speakers

Implicit bias
Ruma Bannerjee (chair), University of Michigan
Mahzarin Banaji, Harvard University

Race as a human construct: We are only human, not a race
Kayunta Johnson–Winters (chair), University of Texas at Arlington
Amanda Bryant–FriedrichWayne State University
Chris GignouxUniversity of Colorado Anschutz Medical Campus
Daniel DawesMorehouse School of Medicine Satcher Health Leadership Institute
Allison C. Augustus–WallaceLouisiana State University Health Sciences Center New Orleans

How selection bias and data interpretation contribute to disparities in health outcomes and artificial intelligence development
Sonia Flores (chair), University of Colorado Denver
Irene Dankwa–MullanIBM Watson Health
Lucio MieleLouisiana State University Health Sciences Center New Orleans
Robert MaupinLouisiana State University Health Sciences Center New Orleans
Rosalina BrayUniversity of Maryland Eastern Shore

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Allison C. Augustus–Wallace
Allison C. Augustus–Wallace

Allison C. Augustus-Wallace is an associate professor-research and director of Undergraduate Academic Pipeline Programs for Diversity at the Louisiana State University Health Sciences Center-New Orleans, School of Medicine, Office of Diversity and Community Engagement and a member of the ASBMB Maximizing Access Committee.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.